Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes
Malika Kapadia(Harvard University), Seth J. Rotz(Cleveland Clinic), Ahna L. H. Pai(University of Cincinnati Medical Center), Kasiani C. Myers(Immune Deficiency Foundation), Veronika Polishchuk(Albert Einstein College of Medicine), Nicole Liberio(Children's Hospital of Wisconsin), Leslie Lehmann(Harvard University), Christa Krupski(Cincinnati Children's Hospital Medical Center), Therese Dodd(Sarah Cannon), Loretta Parker(University of Oklahoma Medical Center), John Huber(Cincinnati Children's Hospital Medical Center), Hannah Ingraham(Cincinnati Children's Hospital Medical Center), Katilyn Kusnier(University of Cincinnati Medical Center), Audrey M. Sigmund(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sagar S. Patel(University of Utah), Mark Mueller(University of Cincinnati Medical Center), David Hartley(Cincinnati Children's Hospital Medical Center), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Laura Flesch(University of Cincinnati Medical Center), Christine Sper(University of Cincinnati Medical Center), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Sarah Tarquini(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Anna Klunk(Cincinnati Children's Hospital Medical Center), Taylor Fitch(University of Cincinnati Medical Center), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Catherine Desmond(Cincinnati Children's Hospital Medical Center), Jeffery J. Auletta(Nationwide Children's Hospital), Kathy Demmel(University of Cincinnati Medical Center), Joseph Maakaron(The Ohio State University), Rita Jakubowski(Children's Hospital of Wisconsin), Lisa Beatty(Flinders University), Mark Juckett(UW Health University Hospital), Rachel Phelan(Children's Hospital of Wisconsin), Robyn Blacken(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 16
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Rural Health Disparities, Population Health, and Rural Culture
|American Journal of Public Health|2004|769
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718